Authors


Jarrett Genovese, PharmD Candidate

Latest:

The Evolution of Specialty Medicine

With the groundbreaking advancements in specialty pharmacy, it is important to recognize the uniqueness of these medications and their respective patient populations.


Kelly Davio

Latest:

Study Shows Similar Efficacy, Safety of Humira Biosimilar

Amgen’s ABP 501 (Amjevita) shows similar efficacy to the reference adalimumab (Humira) in treating rheumatoid arthritis and supported approval of the biosimilar by the FDA.


Joel Claycomb, PharmD

Latest:

Pharmacists In Position to Impact Change for Hepatitis C

Presenters at the International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland identified the current landscape of Hepatitis C, how pharmacists can position themselves to aid in point of care testing, and ways to better educate patients and providers.


Douglas E. Miller, PharmD

Latest:

Enhancing the Strategy for Specialty Pharmaceuticals

Strategies for controlling use of specialty pharmaceuticals should focus on situations where these agents are used inappropriately and on improvement of the complex billing process.





Radhika Jhaveri, PharmD, BCOP

Latest:

First-in-Class Approved Anti-BCMA Therapy: Belantamab Mafodotin-blmf

Belantamab mafodotin-blmf (Blenrep; GlaxoSmithKline) is the first in its class anti-BCMA therapy to gain FDA approval.


Elizabeth Whalley Buono, BSN, RN, MBA, JD

Latest:

Informed Engagement: Unpacking and Addressing Patients' Reasons for Nonadherence

There is no one-size-fits-all solution to the problem of medication nonadherence.




Marc O’Connor, COO, Curant Health

Latest:

Indispensable: Opportunities for Specialty Pharmacy to Deliver Value and Access

Value-based contracts among pharmaceutical manufacturers and payers have not achieved the success levels necessary to drive significant systemic change.



David N. Luter, PharmD

Latest:

Metastatic Breast Cancer Updates

Incremental gains in survival and new targeted agents in the pipeline offer promise.


Justin Smerker, PharmD, MSPBA Candidate

Latest:

5 Keys to Successfully Hiring a Specialty Clinical Pharmacist

Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.


Ashley Branham, PharmD, BCACP

Latest:

Your Practice Is Your Craft: Differentiating Your Community Pharmacy Practice

When you think about recent “disruptors” to the consumer marketplace, you can look around your own neighborhood to see the effects of Uber, Airbnb, and even the craft beer movement.


Hillary Blackburn, PharmD, MBA

Latest:

Restore Hope Through Pharmacy Services

Now, more than ever, is the time that nurses, pharmacists, pharmacy technicians, and physicians can help those who need access to life-saving medicines, and Dispensary of Hope is a resource.



Jeff Lombardo, PharmD, BCOP

Latest:

Current and Future Considerations for the Safe Handling of Hazardous Drugs

Current guidelines suggest that a comprehensive safety program is necessary to reduce hazardous drug exposure in the workplace. 


Sam Mahrous, PhD, MBA, CIS

Latest:

Community Pharmacist Shortage: Fact or Fiction?

What is being done to address current and projected shortages of community pharmacists?


Emily Seamans, 2018 PharmD Candidate, the University of Connecticut

Latest:

Vitamin D: Controversies and Facts

Two-thirds of the US population had sufficient vitamin D status from 2001 to 2006, according to the CDC.


Kristin O'Donovan, PharmD Candidate

Latest:

Why Pharmacy Students Should Master Their Writing Skills

Pharmacy students are taught the importance of communication skills throughout their education.


Alexis Smith, 2018 PharmD Candidate

Latest:

Hospital Formulary Management

The creation and continuous evaluation of a hospital’s formulary facilitates superior patient care, achieves therapeutic goals, and improves patient safety while curtailing expenses.





Esther P. Black, PhD

Latest:

Combating Advancing Cancers With CAR T-Cell Therapy

Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.



Robert B. Parker, PharmD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Bryan Bloom, Cofounder

Latest:

A Look Back and at What Lies Ahead for Specialty Pharmacy in 2019

There is no doubt that 2018 was a year of transformation across the health care spectrum, and specialty pharmacy was no exception.